Storia in 2 fonti

Novo Nordisk CEO looks beyond weight loss to longevity and aesthetics | Fortune

Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight.

Raccontata da

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

fortune.comStai leggendo1 mese fa

Novo itself is beginning to generate data suggesting semaglutide may actually affect biological processes linked to aging, not just body weight.

Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevity and aesthetics.